Does having cancer decrease your risk of developing neurodegenerative diseases? Why do many cancer drug targets overlap with targets for neurodegeneration? Taking place on June 11th from 8:15am - 5:15pm, this interdisciplinary meeting seeks to answer these questions and help attendees learn from the mechanistic insight and years of research on cancer biology to advance new therapeutic development for neurodegenerative diseases. Speakers will address how their research relates to both cancer and neurodegeneration and what we can learn about cell biology and function from these seemingly disparate diseases. Talks will also discuss cancer drug repurposing opportunities for Alzheimer's and related dementias. For more information and registration please visit: www.nyas.org/NDDCancer.
This Event will also be broadcasted as a webinar.
